Barcelona, Spain

Antonio L Cabrera


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 115(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonio L. Cabrera: Innovator in Ophthalmic and Otic Formulations

Introduction

Antonio L. Cabrera, based in Barcelona, Spain, is a noted inventor with significant contributions to the field of pharmaceutical formulations. His innovative approach has led to the creation of a unique formulation that addresses specific medical needs in ophthalmology and otology.

Latest Patents

Cabrera holds a patent for "Diclofenac and tobramycin formulations for ophthalmic and otic topical use." This patent encompasses a pharmaceutically acceptable formulation that includes Diclofenac, Tobramycin, and various solubility agents along with optional excipients, tonicifiers, buffers, viscosity modifying agents, preservatives, and chelating agents. The invention is designed to provide a solution for treating eye and ear conditions that involve both infection and inflammation, with a pH range from greater than 7.0 to about 9.

Career Highlights

Antonio L. Cabrera is affiliated with Laboratorios Cusi, S.A., where he continues to advance his research and development efforts in pharmaceutical formulations. His expertise and innovative thinking have contributed to enhancing the therapeutic options available for patients suffering from eye and ear ailments.

Collaborations

Cabrera collaborates with esteemed colleagues including Michael Van Bergamini and Jose Alberto Vallet Mas. Together, they work on innovative projects aimed at improving health outcomes through effective medical products.

Conclusion

Antonio L. Cabrera's work exemplifies the importance of innovation in the pharmaceutical industry. With his patent on a novel formulation and the collaboration with esteemed professionals, Cabrera continues to make strides in the treatment of ophthalmic and otic conditions, ultimately benefiting patients in need of effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…